The Biospecimen Strategy Lead (BSL) is a senior manager role responsible for the strategic and operational oversight of biospecimen activities in Amgen's clinical trials. The BSL acts as the strategic architect for biospecimen plans within a Therapeutic Area, ensuring scientific integrity and operational excellence to impact patient outcomes.
This role involves: